Canan Yıldız

5PUBLICATIONS

22CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markers

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (5)

Sort by Publication Date:

|May 27, 2026

Does the Duration of FLOT Infusion Change the Outcome of Perioperative Treatment for Gastric Cancer? Comparing 24- and 48-h Infusions.

|Mar 28, 2026

The Effect of HER3 Expression on Prognosis in EGFR-Mutant Non-Small Cell Lung Cancer: A Retrospective Real-World Study.

Canan Yıldız, Meltem Baykara, Hacer Demir

|Jan 24, 2026

Evaluation of inflammatory parameters and ferritin as prognostic factors in non-small cell lung cancer patients receiving nivolumab immunotherapy.

İsmail Beypınar, Onur Yazdan Balçık, Semiha Urvay

|Nov 24, 2025

Prognostic Effect of KELIM Score of Prostate-Specific Antigen in Hormone-Sensitive Prostate Cancer Patients Treated With Novel Androgen Receptor Inhibitors: Pioneering New Ways.

Yusuf Ilhan, Murat Araz, Ali Fuat Gurbuz

|Feb 19, 2025

Prognostic value of IMDC score in non-small cell lung cancer receiving immunotherapy: old dog, new tricks? : IMDC in lung cancer immunotherapy.

İsmail Beypınar, Semiha Urvay, Müslih Ürün

Pageof 1

Frequent Collaborators

Murat Araz

İsmail Beypınar

Semiha Urvay

Muslih Urun

Berrak Mermit Ercek

Onur Yazdan Balçık

Hacer Demir

Yusuf Ilhan

Ali Fuat Gurbuz

Ahmet Oruç

Frequent Collaborators

Murat Araz

İsmail Beypınar

Semiha Urvay

Muslih Urun